1. Home
  2. EZPW vs CINGW Comparison

EZPW vs CINGW Comparison

Compare EZPW & CINGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EZPW
  • CINGW
  • Stock Information
  • Founded
  • EZPW 1989
  • CINGW N/A
  • Country
  • EZPW United States
  • CINGW United States
  • Employees
  • EZPW N/A
  • CINGW 13
  • Industry
  • EZPW Other Specialty Stores
  • CINGW Biotechnology: Pharmaceutical Preparations
  • Sector
  • EZPW Consumer Discretionary
  • CINGW Health Care
  • Exchange
  • EZPW Nasdaq
  • CINGW Nasdaq
  • Market Cap
  • EZPW N/A
  • CINGW N/A
  • IPO Year
  • EZPW 1991
  • CINGW 2021
  • Fundamental
  • Price
  • EZPW $15.32
  • CINGW $0.06
  • Analyst Decision
  • EZPW Strong Buy
  • CINGW
  • Analyst Count
  • EZPW 3
  • CINGW 0
  • Target Price
  • EZPW $17.17
  • CINGW N/A
  • AVG Volume (30 Days)
  • EZPW 1.1M
  • CINGW N/A
  • Earning Date
  • EZPW 04-30-2025
  • CINGW N/A
  • Dividend Yield
  • EZPW N/A
  • CINGW N/A
  • EPS Growth
  • EZPW 77.06
  • CINGW N/A
  • EPS
  • EZPW 1.14
  • CINGW N/A
  • Revenue
  • EZPW $1,181,781,000.00
  • CINGW N/A
  • Revenue This Year
  • EZPW $9.42
  • CINGW N/A
  • Revenue Next Year
  • EZPW $6.85
  • CINGW N/A
  • P/E Ratio
  • EZPW $13.39
  • CINGW N/A
  • Revenue Growth
  • EZPW 8.95
  • CINGW N/A
  • 52 Week Low
  • EZPW $9.65
  • CINGW N/A
  • 52 Week High
  • EZPW $16.35
  • CINGW N/A
  • Technical
  • Relative Strength Index (RSI)
  • EZPW 68.05
  • CINGW N/A
  • Support Level
  • EZPW $14.10
  • CINGW N/A
  • Resistance Level
  • EZPW $16.35
  • CINGW N/A
  • Average True Range (ATR)
  • EZPW 0.59
  • CINGW 0.00
  • MACD
  • EZPW 0.10
  • CINGW 0.00
  • Stochastic Oscillator
  • EZPW 67.30
  • CINGW 0.00

About CINGW Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Share on Social Networks: